Skip to main content
Signal8

FOXO TECHNOLOGIES INC. (FOXO)

FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector. The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings. The dual objectives of these innovations are to encourage greater consumer involvement in their health and wellness, and to streamline the often-complex insurance underwriting process for customers. Among its key offerings is FOXO Labs, a service-oriented platform that enhances the customer underwriting experience by incorporating saliva-based epigenetic biomarkers into expedited underwriting procedures. Additionally, the company provides FOXO Life, an insurance products platform. This platform offers a combination of FOXO's own unique life insurance products and policies from third-party carriers, all designed to bundle longevity science with life insurance. FOXO Technologies Inc. was established in 2019 and is headquartered in Minneapolis, Minnesota.

Sector: Services-Commercial Physical & Biological Research

Industry: Medical - Care Facilities

FOXO Technologies Inc. logo

FOXO Technologies Inc.

OTC:FOXOHealthcare
-11.16%$0.1688
Mkt Cap$280K
EV-
Float1.56M
O/S1.66M
VOL614 sh
$ Vol$99
RVOL0.07×
Inst Own-
Net Cash/Sh-
Dilution

FOXO TECHNOLOGIES INC. (FOXO) dilution facts from SEC filings

Snapshot as of Sep 30, 2026, built from 12 SEC filings.

Shelf registration
None on file in the filings reviewed
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
3 warrant series recorded as outstanding
Most recent offering
PIPE, closed Mar 2, 2026
Source: 10-Q filed Nov 16, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro